Yu-Ping Liao

627 total citations
10 papers, 508 citations indexed

About

Yu-Ping Liao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu-Ping Liao has authored 10 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yu-Ping Liao's work include Epigenetics and DNA Methylation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cervical Cancer and HPV Research (3 papers). Yu-Ping Liao is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cervical Cancer and HPV Research (3 papers). Yu-Ping Liao collaborates with scholars based in Taiwan, India and United States. Yu-Ping Liao's co-authors include Hung‐Cheng Lai, Po‐Hsuan Su, Rui Huang, Yi-Te Yo, Mu‐Hsien Yu, Cheng‐Chang Chang, Hui-Chen Wang, Tai‐Kuang Chao, Yu-Chi Wang and Hsin‐Yi Lee and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Human Molecular Genetics.

In The Last Decade

Yu-Ping Liao

10 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Ping Liao Taiwan 10 363 217 154 95 74 10 508
Jayne Maidens Australia 5 217 0.6× 214 1.0× 97 0.6× 39 0.4× 104 1.4× 5 387
K Ashihara Japan 11 200 0.6× 141 0.6× 139 0.9× 36 0.4× 88 1.2× 16 407
Bożena Konopka Poland 13 319 0.9× 154 0.7× 84 0.5× 50 0.5× 129 1.7× 23 468
Jinxiao Liang China 10 218 0.6× 100 0.5× 83 0.5× 33 0.3× 35 0.5× 27 330
Mitsuyo Yoshida Japan 12 167 0.5× 108 0.5× 121 0.8× 38 0.4× 60 0.8× 20 354
Kui Jiang China 10 182 0.5× 90 0.4× 98 0.6× 48 0.5× 54 0.7× 23 330
Te-Sheng Chang Taiwan 6 146 0.4× 107 0.5× 82 0.5× 95 1.0× 29 0.4× 7 353
Giulia Scotto Italy 10 177 0.5× 99 0.5× 242 1.6× 31 0.3× 83 1.1× 19 458
Satoe Fujiwara Japan 14 279 0.8× 169 0.8× 227 1.5× 37 0.4× 210 2.8× 38 677
Jane Borley United Kingdom 9 294 0.8× 162 0.7× 106 0.7× 14 0.1× 157 2.1× 15 497

Countries citing papers authored by Yu-Ping Liao

Since Specialization
Citations

This map shows the geographic impact of Yu-Ping Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Ping Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Ping Liao more than expected).

Fields of papers citing papers by Yu-Ping Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Ping Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Ping Liao. The network helps show where Yu-Ping Liao may publish in the future.

Co-authorship network of co-authors of Yu-Ping Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Ping Liao. A scholar is included among the top collaborators of Yu-Ping Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Ping Liao. Yu-Ping Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chang, Cheng‐Chang, Hui-Chen Wang, Yu-Ping Liao, et al.. (2017). The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. Journal of Gynecologic Oncology. 29(1). e17–e17. 39 indexed citations
2.
Chao, Tai‐Kuang, Yu-Ping Liao, Rui Huang, et al.. (2017). Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer. PLoS ONE. 12(7). e0182166–e0182166. 47 indexed citations
3.
Huang, Rui, Po‐Hsuan Su, Yu-Ping Liao, et al.. (2016). Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Clinical Cancer Research. 23(1). 263–272. 65 indexed citations
4.
Chang, Cheng‐Chang, Rui Huang, Yu-Ping Liao, et al.. (2015). Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm. BMC Cancer. 15(1). 418–418. 22 indexed citations
5.
Chang, Cheng‐Chang, Rui Huang, Hui-Chen Wang, et al.. (2014). High Methylation Rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 Genes in Cervical Adenocarcinoma. International Journal of Gynecological Cancer. 24(2). 201–209. 49 indexed citations
6.
Huang, Rui, Fei Gu, Nameer B. Kirma, et al.. (2013). Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers. Epigenetics. 8(6). 624–634. 47 indexed citations
7.
Liao, Yu-Ping, Rui Huang, Po‐Hsuan Su, et al.. (2013). Hypomethylation signature of tumor-initiating cells predicts poor prognosis of ovarian cancer patients. Human Molecular Genetics. 23(7). 1894–1906. 55 indexed citations
8.
Yo, Yi-Te, Rui Huang, Yu-Chi Wang, et al.. (2013). Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor. Oncotarget. 4(12). 2366–2382. 18 indexed citations
9.
Wang, Yu-Chi, Yi-Te Yo, Hsin‐Yi Lee, et al.. (2012). ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome. American Journal Of Pathology. 180(3). 1159–1169. 143 indexed citations
10.
Chao, Tai‐Kuang, Yi-Te Yo, Yu-Ping Liao, et al.. (2012). LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial–mesenchymal transition and stem-like properties of epithelial ovarian cancer. Gynecologic Oncology. 128(3). 475–482. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026